This study demonstrates that lipopolysaccharide (LPS) mediates induction of transcription factor NFB and activation of the cytomegalovirus (CMV) promoter-enhancer in the SW480 cell line. These cells do not express a functional membrane CD14. The LPS response in SW480 cells was weaker and markedly slower than the tumor necrosis factor (TNF) response. Pretreatment with TNF for 72 h inhibited both TNF, tumor necrosis factor receptor (TNFR) p55, TNFR p75, and LPS-mediated activation of nuclear factor -B (NFB), whereas pretreatment with LPS only inhibited the LPS response. TNFR p55 antibody pretreatment resulted in marked inhibition of the LPS response, while pretreatment with TNFR p75 antiserum only had a weak inhibitory effect. Flowcytometric analysis showed that LPS binding as well as expression of TNFR p55 and TNFR p75 were not affected by LPS or TNF pretreatment, indicating that the observed inhibition is not due to reduction of specific binding sites at the cell surface. The results suggest that LPS signaling in SW480 cells involves intracellular components which may be depleted or inactivated via TNFR p55, indicating that the LPS and TNFR p55 pathways overlap. We propose that TNFR p55 can mediate activation of NFB and cytomegalovirus promoter-enhancer in SW480 cells via two distinct mechanisms, one which is activated only via TNFR p55 and leads to rapid activation of NFB, and another which is overlapping with the LPS pathway.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. Lockett, M. G. Goebl, and M. A. Harrington Transient membrane recruitment of IRAK-1 in response to LPS and IL-1{beta} requires TNF R1 Am J Physiol Cell Physiol, August 1, 2008; 295(2): C313 - C323. [Abstract] [Full Text] [PDF]

				A. Zwergal, M. Quirling, B. Saugel, K. C. Huth, C. Sydlik, V. Poli, D. Neumeier, H. W. L. Ziegler-Heitbrock, and K. Brand C/EBPbeta Blocks p65 Phosphorylation and Thereby NF-{kappa}B-Mediated Transcription in TNF-Tolerant Cells J. Immunol., July 1, 2006; 177(1): 665 - 672. [Abstract] [Full Text] [PDF]

				M. Weber, C. Sydlik, M. Quirling, C. Nothdurfter, A. Zwergal, P. Heiss, S. Bell, D. Neumeier, H. W. L. Ziegler-Heitbrock, and K. Brand Transcriptional Inhibition of Interleukin-8 Expression in Tumor Necrosis Factor-tolerant Cells: EVIDENCE FOR INVOLVEMENT OF C/EBP{beta} J. Biol. Chem., June 20, 2003; 278(26): 23586 - 23593. [Abstract] [Full Text] [PDF]

				G. Cepinskas, J. Savickiene, C. V. Ionescu, and P. R. Kvietys PMN transendothelial migration decreases nuclear NF{kappa}B in IL-1{beta}-activated endothelial cells: role of PECAM-1 J. Cell Biol., May 12, 2003; 161(3): 641 - 651. [Abstract] [Full Text] [PDF]

				L. Ziegler-Heitbrock The p50-homodimer mechanism in tolerance to LPS Innate Immunity, June 1, 2001; 7(3): 219 - 222. [PDF]

				L. Thommesen, K. Norsett, A. K. Sandvik, E. Hofsli, and A. Lagreid Regulation of Inducible cAMP Early Repressor Expression by Gastrin and Cholecystokinin in the Pancreatic Cell Line AR42J J. Biol. Chem., February 11, 2000; 275(6): 4244 - 4250. [Abstract] [Full Text] [PDF]

				S. Kastenbauer and H. W. L. Ziegler-Heitbrock NF-kappa B1 (p50) Is Upregulated in Lipopolysaccharide Tolerance and Can Block Tumor Necrosis Factor Gene Expression Infect. Immun., April 1, 1999; 67(4): 1553 - 1559. [Abstract] [Full Text] [PDF]

				L. Thommesen, W. Sjursen, K. Gasvik, W. Hanssen, O.-L. Brekke, L. Skattebol, A. K. Holmeide, T. Espevik, B. Johansen, and A. Lagreid Selective Inhibitors of Cytosolic or Secretory Phospholipase A2 Block TNF-Induced Activation of Transcription Factor Nuclear Factor-{kappa}B and Expression of ICAM-1 J. Immunol., October 1, 1998; 161(7): 3421 - 3430. [Abstract] [Full Text] [PDF]

				G. Berntzen, T. H. Flo, A. Medvedev, L. Kilaas, G. Skjåk-Bræk, A. Sundan, and T. Espevik Clin. Vaccine Immunol., May 1, 1998; 5(3): 355 - 361. [Abstract]

				A. Kiani, A. Tschiersch, E. Gaboriau, F. Otto, A. Seiz, H.-P. Knopf, P. Stutz, L. Farber, U. Haus, C. Galanos, et al. Downregulation of the Proinflammatory Cytokine Response to Endotoxin by Pretreatment With the Nontoxic Lipid A Analog SDZ MRL 953 in Cancer Patients Blood, August 15, 1997; 90(4): 1673 - 1683. [Abstract] [Full Text] [PDF]